Search details
1.
Higher beta-hydroxybutyrate ketone levels associated with a slower kidney function decline in ADPKD.
Nephrol Dial Transplant
; 2023 Nov 16.
Article
in English
| MEDLINE | ID: mdl-37974030
2.
Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography - high speed and accuracy.
Eur Radiol
; 33(5): 3222-3231, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36640173
3.
Lanreotide Reduces Liver Growth In Patients With Autosomal Dominant Polycystic Liver and Kidney Disease.
Gastroenterology
; 157(2): 481-491.e7, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31022403
4.
Automatic Measurement of Kidney and Liver Volumes from MR Images of Patients Affected by Autosomal Dominant Polycystic Kidney Disease.
J Am Soc Nephrol
; 30(8): 1514-1522, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31270136
5.
Plasma copeptin levels predict disease progression and tolvaptan efficacy in autosomal dominant polycystic kidney disease.
Kidney Int
; 96(1): 159-169, 2019 07.
Article
in English
| MEDLINE | ID: mdl-30898339
6.
Determinants of Urine Volume in ADPKD Patients Using the Vasopressin V2 Receptor Antagonist Tolvaptan.
Am J Kidney Dis
; 73(3): 354-362, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30578153
7.
A rapid high-performance semi-automated tool to measure total kidney volume from MRI in autosomal dominant polycystic kidney disease.
Eur Radiol
; 29(8): 4188-4197, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-30666443
8.
Case report: a thiazide diuretic to treat polyuria induced by tolvaptan.
BMC Nephrol
; 19(1): 157, 2018 07 03.
Article
in English
| MEDLINE | ID: mdl-29970015
9.
Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1 Randomized Clinical Trial.
JAMA
; 320(19): 2010-2019, 2018 11 20.
Article
in English
| MEDLINE | ID: mdl-30422235
10.
Novel treatment protocol for ameliorating refractory, chronic pain in patients with autosomal dominant polycystic kidney disease.
Kidney Int
; 91(4): 972-981, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28159317
11.
Polycystic Kidney Disease and the Vasopressin Pathway.
Ann Nutr Metab
; 70 Suppl 1: 43-50, 2017.
Article
in English
| MEDLINE | ID: mdl-28614813
12.
Modifiable factors associated with copeptin concentration: a general population cohort.
Am J Kidney Dis
; 65(5): 719-27, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25500109
13.
Estimation of total kidney volume in autosomal dominant polycystic kidney disease.
Am J Kidney Dis
; 66(5): 792-801, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26235803
14.
Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD.
Clin J Am Soc Nephrol
; 19(5): 591-601, 2024 May 01.
Article
in English
| MEDLINE | ID: mdl-38407866
15.
Automated Kidney and Liver Segmentation in MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Study.
Kidney360
; 3(12): 2048-2058, 2022 12 29.
Article
in English
| MEDLINE | ID: mdl-36591351
16.
Effects of Hydrochlorothiazide and Metformin on Aquaresis and Nephroprotection by a Vasopressin V2 Receptor Antagonist in ADPKD: A Randomized Crossover Trial.
Clin J Am Soc Nephrol
; 17(4): 507-517, 2022 04.
Article
in English
| MEDLINE | ID: mdl-35314480
17.
The association of glucagon with disease severity and progression in patients with autosomal dominant polycystic kidney disease: an observational cohort study.
Clin Kidney J
; 14(12): 2582-2590, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34950469
18.
Incident Gallstones During Somatostatin Analog Treatment are Associated with Acute Biliary Complications Especially After Discontinuation.
Drugs R D
; 21(2): 179-188, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33779943
19.
T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease.
Abdom Radiol (NY)
; 43(5): 1215-1222, 2018 05.
Article
in English
| MEDLINE | ID: mdl-28871393
20.
To Add Weight to Overweight.
Clin J Am Soc Nephrol
; 16(6): 850-852, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34117079